Key Patient-Specific Factors Guiding Treatment Selection in CLL

Panelists discuss how various patient-specific factors, including age, comorbidities, performance status, disease aggressiveness, symptoms, and biomarkers, are carefully considered to guide the selection of optimal treatment strategies for individuals with chronic lymphocytic leukemia (CLL).

EP: 1.The Current Treatment Landscape for R/R CLL

EP: 2.Impact of Prior BTKi vs BCL2i Therapy on Treatment Decision-Making in CLL

Now Viewing

EP: 3.Key Patient-Specific Factors Guiding Treatment Selection in CLL

Video content above is prompted by the following:

• What patient-specific factors do you consider to guide treatment selection?(e.g., age, comorbidities, performance status, aggressive/symptomatic disease, biomarkers)

Related Videos